Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 125,104 shares of KURA stock, worth $2.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,104

Previous 86,666 44.35%

Holding current value

$2.4 Million

Previous $1.85 Million 39.34%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $673,818 - $883,305	38,438 Added 44.35%	125,104 $2.58 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $64,550 - $113,179	4,810 Added 5.88%	86,666 $1.85 Million
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $353,526 - $496,779	41,887 Added 104.8%	81,856 $746,000
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $63,724 - $86,870	-5,950 Reduced 12.96%	39,969 $488,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $3.54 Million - $5.73 Million	-294,543 Reduced 86.51%	45,919 $627,000
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $107,838 - $184,564	-10,069 Reduced 2.87%	340,462 $6.24 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $249,959 - $360,298	-21,219 Reduced 5.71%	350,531 $5.64 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $139,124 - $222,804	-11,385 Reduced 2.97%	371,750 $5.2 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $146,921 - $206,948	-9,528 Reduced 2.43%	383,135 $7.18 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $1.93 Million - $2.77 Million	92,687 Added 30.9%	392,663 $8.19 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $1.01 Million - $1.59 Million	40,660 Added 15.68%	299,976 $8.48 Million
Q4 2020 Mar 01, 2021	BUY	$29.0 - $41.62 $6.4 Million - $9.18 Million	220,616 Added 570.07%	259,316 $8.47 Million
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $7,498 - $14,094	460 Added 1.2%	38,700 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $180,655 - $427,438	22,724 Added 146.46%	38,240 $623,000
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $53,386 - $116,209	-8,277 Reduced 34.79%	15,516 $154,000
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $1,569 - $1,928	121 Added 0.51%	23,793 $327,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $349,162 - $494,034	23,672 New	23,672 $359,000

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.29B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History